scholarly journals Pediatric type 1 diabetes mellitus and COVID-19 infection: is there an association?

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Michael Yafi ◽  
Priscille Donate ◽  
Nunilo Rubio ◽  
Michelle Velez ◽  
Avni Shah
Keyword(s):  
Type 1 Diabetes ◽  
Epidemiological Data ◽  
Early Screening ◽  
Pediatric Diabetes ◽  
New Type ◽  
The Uk ◽  
Spread Of Infection ◽  
Pediatric Type 1 Diabetes ◽  
Screening And Diagnosis

A recent study from the UK, has described an apparent increase in new type 1 diabetes (T1DM) onset in children during COVID-19 pandemic. Both Brazil and USA (including our area of Houston, TX) have recently suffered from a sudden surge of this infection and we have noticed an association between the infection and 2 new cases of pediatric diabetes presenting in diabetes ketoacidosis. This association may become important in the future if the epidemiological data of T1DM shows an increased trend post the COVID-19 infection. It is also important to note that one patient was asymptomatic, this may be important to consider early screening and diagnosis to prevent the spread of infection.

scholarly journals Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?

2020 ◽  
Author(s):  
Ivana Rabbone ◽  
Riccardo Schiaffini ◽  
Valentino Cherubini ◽  
Claudio Maffeis ◽  
Andrea Scaramuzza ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cross Sectional ◽  
Web Based ◽  
Pediatric Diabetes ◽  
Acute Complications ◽  
Design And Methods ◽  
Second Wave ◽  
Pediatric Type 1 Diabetes ◽  
New Onset

<div><b>Objective</b>: To evaluate if the diagnosis of pediatric type 1 diabetes or its acute complications changed during the early phase of the COVID-19 pandemic in Italy.<b><br></b></div><div><b>Research Design and Methods</b>: This was a cross-sectional, web-based survey of all Italian pediatric diabetes centers to collect diabetes, diabetes ketoacidosis (DKA), and COVID-19 data in patients presenting with new-onset or established type 1 diabetes between February 20 and April 14 in 2019 and 2020. </div><div><b>Results</b>: 53/68 centers (77.9%) responded. There was a 23% reduction in new diabetes cases in 2020 compared to 2019. Among those newly diagnosed patient who presented in DKA, the proportion with severe DKA was 44.3% in 2020 vs 36.1% in 2019, p = 0.03. There were no differences in acute complications. Eight patients with asymptomatic or mild COVID-19 had laboratory-confirmed SARS-CoV-2.<b><br></b></div><div><b>Conclusions</b>: The COVID-19 pandemic might have altered diabetes presentation and DKA severity. Preparing for any “second wave” requires strategies to educate and reassure parents about timely ED attendance for non-COVID-19 symptoms.</div>

scholarly journals Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children?

2020 ◽  
Author(s):  
Ivana Rabbone ◽  
Riccardo Schiaffini ◽  
Valentino Cherubini ◽  
Claudio Maffeis ◽  
Andrea Scaramuzza ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cross Sectional ◽  
Web Based ◽  
Pediatric Diabetes ◽  
Acute Complications ◽  
Design And Methods ◽  
Second Wave ◽  
Pediatric Type 1 Diabetes ◽  
New Onset

<div><b>Objective</b>: To evaluate if the diagnosis of pediatric type 1 diabetes or its acute complications changed during the early phase of the COVID-19 pandemic in Italy.<b><br></b></div><div><b>Research Design and Methods</b>: This was a cross-sectional, web-based survey of all Italian pediatric diabetes centers to collect diabetes, diabetes ketoacidosis (DKA), and COVID-19 data in patients presenting with new-onset or established type 1 diabetes between February 20 and April 14 in 2019 and 2020. </div><div><b>Results</b>: 53/68 centers (77.9%) responded. There was a 23% reduction in new diabetes cases in 2020 compared to 2019. Among those newly diagnosed patient who presented in DKA, the proportion with severe DKA was 44.3% in 2020 vs 36.1% in 2019, p = 0.03. There were no differences in acute complications. Eight patients with asymptomatic or mild COVID-19 had laboratory-confirmed SARS-CoV-2.<b><br></b></div><div><b>Conclusions</b>: The COVID-19 pandemic might have altered diabetes presentation and DKA severity. Preparing for any “second wave” requires strategies to educate and reassure parents about timely ED attendance for non-COVID-19 symptoms.</div>

A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Trans-Atlantic Comparison

2020 ◽  
Author(s):  
Ananta Addala ◽  
Marie Auzanneau ◽  
Kellee Miller ◽  
Werner Maier ◽  
Nicole Foster ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Technology Use ◽  
Hemoglobin A1c ◽  
Diabetes Technology ◽  
Design And Methods ◽  
Relationship Of ◽  
The Relationship ◽  
Pediatric Type 1 Diabetes

<b>Objective:</b> As diabetes technology use in youth increases worldwide, inequalities in access may exacerbate disparities in hemoglobin A1c (HbA1c). We hypothesized an increasing gap in diabetes technology use by socioeconomic status (SES) would be associated with increased HbA1c disparities. <p> </p> <p><b>Research Design and Methods: </b>Participants aged <18 years with diabetes duration ≥1 year in the Type 1 Diabetes Exchange (T1DX, US, n=16,457) and Diabetes Prospective Follow-up (DPV, Germany, n=39,836) registries were categorized into lowest (Q1) to highest (Q5) SES quintiles. Multiple regression analyses compared the relationship of SES quintiles with diabetes technology use and HbA1c from 2010-2012 and 2016-2018. </p> <p> </p> <p><b>Results: </b>HbA1c was higher in participants with lower SES (in 2010-2012 & 2016-2018, respectively: 8.0% & 7.8% in Q1 and 7.6% & 7.5% in Q5 for DPV; and 9.0% & 9.3% in Q1 and 7.8% & 8.0% in Q5 for T1DX). For DPV, the association between SES and HbA1c did not change between the two time periods, whereas for T1DX, disparities in HbA1c by SES increased significantly (p<0.001). After adjusting for technology use, results for DPV did not change whereas the increase in T1DX was no longer significant.</p> <p> </p> <p><b>Conclusions: </b>Although causal conclusions cannot be drawn, diabetes technology use is lowest and HbA1c is highest in those of the lowest SES quintile in the T1DX and this difference for HbA1c broadened in the last decade. Associations of SES with technology use and HbA1c were weaker in the DPV registry. </p>

scholarly journals Paediatric rotavirus vaccination, coeliac disease and type 1 diabetes in children: a population-based cohort study

BMC Medicine ◽  
2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Thomas Inns ◽  
Kate M. Fleming ◽  
Miren Iturriza-Gomara ◽  
Daniel Hungerford
Keyword(s):  
Type 1 Diabetes ◽  
Cohort Study ◽  
Coeliac Disease ◽  
Practice Research ◽  
Clinical Practice Research Datalink ◽  
Rotavirus Vaccine ◽  
Rotavirus Vaccination ◽  
Increased Risk ◽  
The Uk

Abstract Background Rotavirus infection has been proposed as a risk factor for coeliac disease (CD) and type 1 diabetes (T1D). The UK introduced infant rotavirus vaccination in 2013. We have previously shown that rotavirus vaccination can have beneficial off-target effects on syndromes, such as hospitalised seizures. We therefore investigated whether rotavirus vaccination prevents CD and T1D in the UK. Methods A cohort study of children born between 2010 and 2015 was conducted using primary care records from the Clinical Practice Research Datalink. Children were followed up from 6 months to 7 years old, with censoring for outcome, death or leaving the practice. CD was defined as diagnosis of CD or the prescription of gluten-free goods. T1D was defined as a T1D diagnosis. The exposure was rotavirus vaccination, defined as one or more doses. Mixed-effects Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CIs). Models were adjusted for potential confounders and included random intercepts for general practices. Results There were 880,629 children in the cohort (48.8% female). A total of 343,113 (39.0%) participants received rotavirus vaccine; among those born after the introduction of rotavirus vaccination, 93.4% were vaccinated. Study participants contributed 4,388,355 person-years, with median follow-up 5.66 person-years. There were 1657 CD cases, an incidence of 38.0 cases per 100,000 person-years. Compared with unvaccinated children, the adjusted HR for a CD was 1.05 (95% CI 0.86–1.28) for vaccinated children. Females had a 40% higher hazard than males. T1D was recorded for 733 participants, an incidence of 17.1 cases per 100,000 person-years. In adjusted analysis, rotavirus vaccination was not associated with risk of T1D (HR = 0.89, 95% CI 0.68–1.19). Conclusions Rotavirus vaccination has reduced diarrhoeal disease morbidity and mortality substantial since licencing in 2006. Our finding from this large cohort study did not provide evidence that rotavirus vaccination prevents CD or T1D, nor is it associated with increased risk, delivering further evidence of rotavirus vaccine safety.

scholarly journals A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET)

2016 ◽  
Vol 17 ◽  
pp. 24-31 ◽  
Author(s):  
Danièle Pacaud ◽  
Anke Schwandt ◽  
Carine de Beaufort ◽  
Kristina Casteels ◽  
Jacques Beltrand ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Type 1 Diabetes ◽  
Diabetes Registry ◽  
Pediatric Diabetes
Sign in / Sign up

Export Citation Format

Share Document